Impact of tumor environments on susceptibility and course of disease in those infected with SARS-CoV-2

By | December 13, 2021
A review assessed the impact of “hot” vs. “cold” immune/tumor environments (and associated therapies) on susceptibility and disease course in subjects with these two types of tumors and infected with SARS-CoV-2 to decipher the mechanisms that drive these adverse outcomes in COVID-19 infected cancer patients.